Kusajili – Clinical trials directory

Result of your search per sponsor: Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany

Woman and Man Max 99 years
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany Update Il y a 4 ans

A four-arm randomised, double-blind, placebo-controlled, multicentre Phase II study to evaluate the safety, tolerability and efficacy as assessed by frequent MRI measures of three doses of atacicept monotherapy in subjects with relapsing multiple sclerosis (RMS) over a 36 weeks treatment course The primary objective of the study is to evaluate the efficacy of three doses of atacicept to reduce CNS inflammation in subjects with RMS as assessed by frequent MRI.

Country None
organs None
Specialty None

Closed trial

More information